Shares of Alembic Pharma hit a fresh 52-week low after the company’s board approved Rs 1,150 crore impairment charges for three manufacturing facilities in Gujarat.
Shares of Alembic Pharma hit a fresh 52-week low after the company’s board approved Rs 1,150 crore impairment charges for three manufacturing facilities in Gujarat.